BIZTRAC BETA
Retail sale of pharmaceutical products

ANDEBU APOTEK AS

Org. no. 993328774 Limited company (AS) Sandefjord Incorporated 2008 Active
Ownership graph ↗
Revenue 2024 NOK 28.6m
Operating profit NOK 380,000
Equity NOK −173,000
Incorporated 2008
Share capital NOK 200,000

Signals

1 flags
  • Negativ egenkapital 2024 Bokført egenkapital er negativ (−173k kr).

ANDEBU APOTEK AS is registered as a limited company in Sandefjord, Vestfold with organisation number 993328774. The business is classified under retail sale of pharmaceutical products (NACE 47.730). The company was incorporated in 2008. Registered share capital is NOK 200,000, divided into 10000 shares. The company's stated purpose is: “Apotekvirksomhet.”. The most recent filed accounts, for the 2024 financial year, show NOK 28.6m in revenue and NOK 380,000 in operating profit.

Key figures · 2024

Revenue
NOK 28.6m
Operating profit
NOK 380,000
Equity
NOK −173,000
Est. value
NOK 2.7m

Financial health · 2024

Liquidity
0.52
Weak
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
-3.9%
Weak
Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns ANDEBU APOTEK AS?

GOKSTADAPOTEKENE AS
ANDEBU APOTEK AS
NOK 28.6m rev. · NOK 380,000 profit

ANDEBU APOTEK AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about ANDEBU APOTEK AS

Who owns ANDEBU APOTEK AS?

GOKSTADAPOTEKENE AS is the largest registered owner, with 100.0%.

What is the revenue of ANDEBU APOTEK AS?

ANDEBU APOTEK AS had revenue of NOK 28.6m in 2024.

Who is the general manager of ANDEBU APOTEK AS?

Slawomir Mazur is registered as general manager of ANDEBU APOTEK AS.

Where is ANDEBU APOTEK AS based?

ANDEBU APOTEK AS has its business address in Andebu.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.